Skip to main content
OpenTrials
Completed

NCT Number: NCT05746936

Robotic Versus Laparoscopic Roux En-y Gastric Bypass

This study retrospectively identified 33 consecutive obese patients who underwent either laparoscopic or robotic gastric bypass procedures over a 2-year period.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Body mass index (BMI) ≥35-39 kg/m2 with one obesity- associated co-morbidity
  • BMI≥40kg/m2, age ≥ 18 years.

Exclusion criteria

  • Re-do surgery procedures

Treatment and study plan

Roux en-Y gastric bypass

Procedure

gastric bypass with jejuna-jenual anastomosis and gusto-jejunal anastomosis

Primary outcomes

  1. differences between the robotic and laparoscopic gastric bypass

    Time frame: two years period

    incidence of mortality and morbidity (percentage)

  2. differences between the robotic and laparoscopic gastric bypass

    Time frame: two years period

    BMI ( kg/m2)

  3. differences between the robotic and laparoscopic gastric bypass

    Time frame: two years period

    age (years)

  4. differences between the robotic and laparoscopic gastric bypass

    Time frame: two years period

    weight (kg)

Sponsors and collaborators

Lead sponsor

University of Foggia

Other

Registry information

Official study title

Can Robotic Gastric Bypass be Considered a Valid Alternative to Laparoscopy: Our Early Experience

Important dates

Study start
2020
Primary completion
2022
Study completion
2023
First posted
Feb 28, 2023
Registry last updated
Feb 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.